QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 1, 2006, 26(5):1604-1615; doi:10.1523/JNEUROSCI.4722-05.2006

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (35) Citing Articles via Google Scholar Google Scholar Articles by Kinney, J. W. Articles by Behrens, M. M. Search for Related Content PubMed PubMed Citation Articles by Kinney, J. W. Articles by Behrens, M. M.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
A Specific Role for NR2A-Containing NMDA Receptors in the Maintenance of Parvalbumin and GAD67 Immunoreactivity in Cultured Interneurons

Jefferson W. Kinney, Christopher N. Davis, Iustin Tabarean, Bruno Conti, Tamas Bartfai, and M. Margarita Behrens

The Harold L. Dorris Neurological Research Center, Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, California 92037

Correspondence should be addressed to M. Margarita Behrens, Division of Geriatrics, Department of Medicine, University of California San Diego, Stein Clinical Research Building, Room 126, La Jolla, CA 92093. Email: mbehrens{at}ucsd.edu

Several lines of evidence suggest that a hypoglutamatergic condition may induce a phenotypic loss of cortical parvalbumin (PV)-positive GABAergic interneurons, such as that observed in brain tissue of schizophrenic subjects. However, it is not known whether the loss of PV interneurons is a consequence of the hypoglutamatergic condition or a secondary aspect of the disease. We characterized the signaling and subunit expression of NMDA receptors in cultured cortical PV interneurons and determined whether a hypoglutamatergic condition, created by direct application of sublethal concentrations of ketamine or subunit-selective NMDA receptor antagonists, can affect the expression of the GABAergic markers as observed in vivo. Real-time PCR performed on mRNA isolated from single neurons showed that PV interneurons present a fivefold higher NR2A/NR2B ratio than pyramidal neurons. Brief, nontoxic, exposure to NMDA led to an increase in ERK1/2 (extracellular signal-regulated kinase 1/2) and cAMP response element-binding protein phosphorylation in PV interneurons, and this increase was blocked by the NR2A-selective antagonist NVP-AAM077. Application of the nonselective NMDA receptor antagonist ketamine, at sublethal concentrations, induced a time and dose-dependent decrease in parvalbumin and GAD67 immunoreactivity specifically in PV interneurons. These effects were reversible and were also observed with the NR2A-selective antagonist, whereas the NR2B-selective antagonist Ro-25-6981 only partially reduced GAD67 immunoreactivity. Coexposure to the calcium channel opener BayK, or the group I metabotropic glutamate receptor agonist DHPG [(RS)-3,5-dihydroxyphenylglycine] attenuated the decrease in GAD67 and parvalbumin induced by the NMDA receptor antagonists. These results suggest that the activity of NR2A-containing NMDA receptors play a pivotal role in the maintenance of the GABAergic function of PV interneurons.

Key words: NMDA receptors; parvalbumin; hypoglutamatergic; GABAergic; schizophrenia; mGluR5

---

Received July 28, 2005; revised Dec. 19, 2005; accepted Dec. 21, 2005.

Correspondence should be addressed to M. Margarita Behrens, Division of Geriatrics, Department of Medicine, University of California San Diego, Stein Clinical Research Building, Room 126, La Jolla, CA 92093. Email: mbehrens{at}ucsd.edu

This article has been cited by other articles:

				R. S. Saliba, Z. Gu, Z. Yan, and S. J. Moss Blocking L-type Voltage-gated Ca2+ Channels with Dihydropyridines Reduces {gamma}-Aminobutyric Acid Type A Receptor Expression and Synaptic Inhibition J. Biol. Chem., November 20, 2009; 284(47): 32544 - 32550. [Abstract] [Full Text] [PDF]

				A. Desfeux, F. El Ghazi, S. Jegou, H. Legros, S. Marret, V. Laudenbach, and B. J. Gonzalez Dual Effect of Glutamate on GABAergic Interneuron Survival during Cerebral Cortex Development in Mice Neonates Cereb Cortex, September 16, 2009; (2009) bhp181v1. [Abstract] [Full Text] [PDF]

				Z. J. Huang Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond J. Physiol., May 1, 2009; 587(9): 1881 - 1888. [Abstract] [Full Text] [PDF]

				M. M. Behrens, S. S. Ali, and L. L. Dugan Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia J. Neurosci., December 17, 2008; 28(51): 13957 - 13966. [Abstract] [Full Text] [PDF]

				A. Benali, E. Weiler, Y. Benali, H. R. Dinse, and U. T. Eysel Excitation and Inhibition Jointly Regulate Cortical Reorganization in Adult Rats J. Neurosci., November 19, 2008; 28(47): 12284 - 12293. [Abstract] [Full Text] [PDF]

				Y. Luo, J. Lathia, M. Mughal, and M. P. Mattson SDF1{alpha}/CXCR4 Signaling, via ERKs and the Transcription Factor Egr1, Induces Expression of a 67-kDa Form of Glutamic Acid Decarboxylase in Embryonic Hippocampal Neurons J. Biol. Chem., September 5, 2008; 283(36): 24789 - 24800. [Abstract] [Full Text] [PDF]

				A. K. Roopun, M. O. Cunningham, C. Racca, K. Alter, R. D. Traub, and M. A. Whittington Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 962 - 973. [Abstract] [Full Text] [PDF]

				G. Gonzalez-Burgos and D. A. Lewis GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 944 - 961. [Abstract] [Full Text] [PDF]

				Y. Zhang, M. M. Behrens, and J. E. Lisman Prolonged Exposure to NMDAR Antagonist Suppresses Inhibitory Synaptic Transmission in Prefrontal Cortex J Neurophysiol, August 1, 2008; 100(2): 959 - 965. [Abstract] [Full Text] [PDF]

				M. M. Behrens, S. S. Ali, D. N. Dao, J. Lucero, G. Shekhtman, K. L. Quick, and L. L. Dugan Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase Science, December 7, 2007; 318(5856): 1645 - 1647. [Abstract] [Full Text] [PDF]

				P. A. Frizelle, P. E. Chen, and D. J. A. Wyllie Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-D-aspartate Receptors: Implications for Studies of Synaptic Transmission Mol. Pharmacol., September 1, 2006; 70(3): 1022 - 1032. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help